Ashley Gallagher, Editor

The implementation allowed pharmacists to use online technology in anticoagulation clinics, which increased referrals and led to more accessibility, study results show.

Study results show that during a 1-year period, more than 15 patient care areas underwent rapid changes.

Sotrovimab demonstrated ongoing activity against all tested COVID-19 variants of concern and interest, as defined by the World Health Organization.

These materials are present in some angiotensin II receptor blockers used to treat heart failure and high blood pressure, and they have the potential to cause cancer.

Jaime Bridges, opioid outreach coordinator at Orlando Health Orlando Regional Medical Center, and Kris Smith, PharmD, clinical pharmacy specialist for internal medicine at Orlando Health Orlando Regional Medical Center discuss how COVID-19 has affected the opioid crisis and what opioid-free pain management options are available as alternatives.

Study results show that those who completed CBT-AD sessions were more than 2.5 times more likely to achieve undetectable viral loads than those who underwent the usual care.

The diagnostic tool widens the age group of individuals who can get tested and can be used in conjunction with a mammogram.

A more customized approach could be beneficial in terms of reducing illness via lifestyle and medication intervention monitoring.

Study results show that fetal cognitive development in the assessed areas was age-appropriate and there was no indication of infection.

Study results show more activity in brain areas affecting sympathy and movement when the women viewed the photos.

Investigators focus on the relationship with neuron activity and find that sodium consumption plays a role.

Individuals taking selective serotonin reuptake inhibitors, particularly fluoxetine (Prozac), were less likely to die of the virus than those in a matched control group, study results show.

Taking the medication is linked to a 26% increase in new HF diagnosis, results of a study published in ESC Heart Failure show.

The odds of visiting an ED for anxiety were 2.8 times greater than for non-depressed individuals.

The results of a study show the chance of death for those with cancer taking rituximab was more than double that of medically similar people.

Survey results may imply that individuals who stop could have more health problems or die from a subsequent heart issue.

Lomecel-B (Longeveron) is an investigational allogeneic, bone marrow-derived medicinal signaling cell medication that is being evaluated in a phase 2 trial.

The device is to be worn on the stomach and senses when an individual stops breathing and moving, followed by an injection of naloxone that can restore respiration.

The VANISH-303 and VANISH-306 studies provide analysis of tablets that treat vulvovaginal candidiasis, which is vaginal yeast infection.

An embryonic stem cell model allowed investigators to study the genetic architecture first in hypothalamic progenitor cells, prior to their full development, and then nucleus-like hypothalamic neurons.

Non-classical monocytes, a type of innate immune cell that signals molecule to alert other immune cells to threats, could be potential target for COVID-19 therapies.

About 29% of the risk for obsessive-compulsive disorder is attributable to differences in single nucleotide polymorphisms between individuals and the control group, study results show.

The model could help researchers and public health officials interpret the significance of existing variants and design tailored public health responses for various scenarios based on a variant’s characteristic.

The cells, named nexus glia, resemble critical glial cells called astrocytes in the brain, and when these cells were removed, heart rate increased.

Physicians advised the individual to adopt the Low Inflammatory Foods Everyday (LIFE) diet, which is a nutrient dense, whole food, plant-based diet.

Within 1 or 2 days of injury, therapeutic B cells release a complex mix of specific pro- and anti-inflammatory molecules, which can affect molecular processing and facilitate healing.

The results showed that one 300 mg dose of AZD7442 reduced the risk of developing symptomatic COVID-19 by 83% and one 600 mg dose reduced the risk of developing severe COVID-19 or death (from any cause) by 88% compared to the placebo.

Investigators have developed an encapsulated and immobilized individual bacterium cell in crystalline polymeric matric that not only kills the bacterium but preserves and stabilizes the dead cell against high temperature, moisture, and organic solvents. The method utilizes metal-organic frameworks (MOFs).

Survey results show 81% think the psychoactive drug will play a role in chronic pain management.

Almost 80% of individuals with type 2 diabetes lost more than 22 pounds and maintained that weight loss in remission for at least 2 years, study results show.